Elanco Animal Health Inc [NYSE: ELAN] closed the trading session at $14.2 on 2025-08-05. The day’s price range saw the stock hit a low of $13.97, while the highest price level was $14.38.
The stocks have a year to date performance of 8.90 percent and weekly performance of -1.32 percent. The stock has been moved at 21.16 percent over the last six months. The stock has performed -1.87 percent around the most recent 30 days and changed 47.15 percent over the most recent 3-months.
If compared to the average trading volume of 5.75M shares, ELAN reached to a volume of 6894111 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Elanco Animal Health Inc [ELAN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $16.27 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Elanco Animal Health Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 17, 2025. The new note on the price target was released on June 26, 2025, representing the official price target for Elanco Animal Health Inc stock. Previously, the target price had yet another raise to $18, while UBS analysts kept a Buy rating on ELAN stock.
The Price to Book ratio for the last quarter was 1.11, with the Price to Cash per share for the same quarter was set at 0.98. Price to Free Cash Flow for ELAN in the course of the last twelve months was 20.32 with Quick ratio for the last quarter at 1.46.
ELAN stock trade performance evaluation
Elanco Animal Health Inc [ELAN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.32. With this latest performance, ELAN shares dropped by -1.87% in over the last four-week period, additionally plugging by 21.16% over the last 6 months – not to mention a rise of 17.26% in the past year of trading.
Elanco Animal Health Inc [ELAN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Elanco Animal Health Inc [ELAN] shares currently have an operating margin of 5.40% and a Gross Margin at 43.10%. Elanco Animal Health Inc’s Net Margin is presently recorded at 8.43%.
Elanco Animal Health Inc (ELAN) Capital Structure & Debt Analysis
According to recent financial data for Elanco Animal Health Inc. ( ELAN), the Return on Equity (ROE) stands at 6.01%, suggesting modest shareholder returns. The Return on Assets (ROA) is 2.77%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Elanco Animal Health Inc’s Return on Invested Capital (ROIC) is 3.48%, showcasing its effectiveness in deploying capital for earnings.
Elanco Animal Health Inc (ELAN) Efficiency & Liquidity Metrics
Based on Elanco Animal Health Inc’s (ELAN) latest financial statements, the Debt-to-Equity Ratio is 0.69%, indicating its reliance on debt financing relative to shareholder equity.
Elanco Animal Health Inc (ELAN) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Elanco Animal Health Inc. (ELAN) effectively leverages its workforce, generating an average of $39470.9 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.71% and a Quick Ratio of 1.46%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Elanco Animal Health Inc [ELAN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Inc go to 6.19%.
Elanco Animal Health Inc [ELAN]: Institutional Ownership
There are presently around $103.05%, or 104.12% of ELAN stock, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: DODGE & COX with ownership of 83.58 million shares, which is approximately 16.9128%. PRIMECAP MANAGEMENT CO/CA/, holding 52.8 million shares of the stock with an approximate value of $$761.94 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $$713.53 million in ELAN stock with ownership which is approximately 10.0056%.
